Sarepta Therapeutics, Inc. (SRPT) Social Stream
SAREPTA THERAPEUTICS INC (SRPT) Price Targets From Analysts
Use the tables below to see what analysts covering SAREPTA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 17 | $160 | $90 | $127.25 | $110.08 | 15.6% |
| 2021-12-26 | 16 | $160 | $90 | $127.076 | $110.08 | 15.44% |
| 2022-01-05 | 16 | $160 | $90 | $126.538 | $110.08 | 14.95% |
| 2022-01-11 | 13 | $160 | $90 | $128.083 | $110.08 | 16.35% |
| 2022-01-19 | 14 | $160 | $90 | $128.083 | $110.08 | 16.35% |
| 2022-01-26 | 14 | $160 | $92 | $126.833 | $110.08 | 15.22% |
| 2022-02-09 | 14 | $160 | $71 | $125.083 | $110.08 | 13.63% |
| 2022-03-04 | 13 | $150 | $71 | $121.909 | $110.08 | 10.75% |
| 2022-03-07 | 13 | $150 | $80 | $122.727 | $110.08 | 11.49% |
| 2022-03-16 | 13 | $150 | $80 | $123 | $110.08 | 11.74% |
| 2022-04-04 | 13 | $150 | $80 | $124.3 | $110.08 | 12.92% |
| 2022-04-12 | 13 | $150 | $77 | $124 | $110.08 | 12.65% |
| 2022-04-20 | 13 | $150 | $77 | $124.2 | $110.08 | 12.83% |
| 2022-05-09 | 13 | $150 | $77 | $124.1 | $110.08 | 12.74% |
| 2022-05-13 | 13 | $150 | $77 | $124.6 | $110.08 | 13.19% |
| 2022-05-18 | 13 | $150 | $74 | $124.3 | $110.08 | 12.92% |
| 2022-05-24 | 14 | $155 | $74 | $127.09 | $110.08 | 15.45% |
| 2022-06-22 | 13 | $155 | $74 | $127.09 | $110.08 | 15.45% |
| 2022-07-25 | 13 | $155 | $80 | $126.272 | $110.08 | 14.71% |
| 2022-07-29 | 13 | $162 | $80 | $127.363 | $110.08 | 15.7% |
| 2022-08-03 | 13 | $162 | $80 | $127.583 | $110.08 | 15.9% |
| 2022-08-04 | 13 | $162 | $100 | $132.076 | $110.08 | 19.98% |
| 2022-08-09 | 13 | $182 | $100 | $133.769 | $110.08 | 21.52% |
| 2022-08-13 | 13 | $182 | $100 | $134.923 | $110.08 | 22.57% |
| 2022-08-18 | 13 | $182 | $100 | $136.461 | $110.08 | 23.97% |
The Trend in the Analyst Price Target
SRPT's average price target has moved up $13.73 over the prior 164 days.
Over the past 50 weeks, SRPT's average upside potential has been 56.66%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-03 | 21 | 199 | 75 | 119.470 | 80.51 | 48.39% |
| 2021-12-09 | 16 | 160 | 90 | 127.076 | 85.46 | 48.7% |
| 2022-01-11 | 13 | 160 | 90 | 128.083 | 76.34 | 67.78% |
| 2022-02-09 | 14 | 150 | 71 | 121.909 | 78.89 | 54.53% |
| 2022-07-29 | 13 | 162 | 80 | 127.363 | 92.95 | 37.02% |
SRPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.46 | 9 | 2 | 2 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
SRPT's average broker recommendation rating improved by 0.16 over the prior 35 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SAREPTA THERAPEUTICS INC's number of analysts covering the stock is greater than 2416.02% of Pharmaceutical Products stocks.
- In terms of how SAREPTA THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 2409.35% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAREPTA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 298.65% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, SAREPTA THERAPEUTICS INC's variance in analysts' estimates is lower than -1792.01% of them.
Stocks similar to SAREPTA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SNY, RPRX, and REGN.
View All Top Stocks by Price Target
Make investment decisions regarding SRPT using the data that counts. Try POWR Ratings for free.